Engine Biosciences

Engine Biosciences

Private
SingaporeHealthcare & Life Scienceshttps://www.enginebio.com

Last Round

Series A

Extension

Oct 31, 2023

Total Funding Raised

$80M

Momentum Score

25 /100

Company Overview

Engine Biosciences is a biotechnology company that offers a network biomedicine platform for mapping and understanding complex biological networks to enhance drug discovery processes.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

AI drug discoverydrug discovery platformprecision medicinetechbiooncologydrug target discoverybiomarker discoveryAI-native drug discoverycomputational biologynetwork biologyin-silico drug discoveryhigh-throughput biologycombinatorial geneticscombinatorial CRISPR screenspatient selection biomarkerspharmaceutical partnershipsPKMYT1 target

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Engine Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Engine Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 31, 2023
Series AMay 26, 2021
SeedJan 31, 2018

Key People

Founding team and executive leadership

Jeffrey Lu

Co-Founder And CEO

Founding Team

Engine Biosciences Investors

Notable investors and investment history

InvestorRounds
Baidu VenturesSeries A, Seed
Nest Bio VenturesSeries A, Seed
SEEDS CapitalSeries A Extension
Vectr VenturesSeries A
Camford CapitalSeries A, Seed
WI Harper GroupSeries A, Seed
ClavystBioSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2025

    Partnered with the Experimental Drug Development Centre (EDDC).

Engine Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Engine Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Engine Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range31
Year Founded2014
Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.